openPR Logo
Press release

Ventricular Tachycardia Treatment Market Segmentation and Competitor Analysis Report 2017 – 2025

08-18-2017 12:58 PM CET | Health & Medicine

Press release from: Persistence Market Research

Ventricular Tachycardia Treatment Market Segmentation

Ventricular tachycardia is a life threatening heart condition in which arrhythmic heart beats occur in the ventricles. The two lower chambers of the heart are known as ventricles. They are responsible for supplying the blood received from atria to different parts of the body. When a person suffers from ventricular tachycardia, a high pulse with more than 100 beats per minute is registered with minimum 3 irregular heartbeats experienced in a row. It is most commonly indicated in patients having acute myocardial infarction, electrolyte abnormalities and idiopathic ventricular arrhythmia in heart. Ventricular tachycardia should be correctly diagnosed in time as it may lead to hemodynamic instability causing ventricular fibrillation, thereby becoming a major reason behind deaths due to cardiac attacks. Ventricular tachycardia can be further classified into four different types which includes monomorphic, polymorphic, sustained and non-sustained ventricular tachycardia. In non-sustained ventricular tachycardia, heartbeat stops impulsively without disturbing the blood flow; whereas, in sustained ventricular tachycardia arrhythmic heartbeats persists for more than 30 seconds and they usually disrupts the blood flow by lowering it. However, in monomorphic ventricular tachycardia, the heartbeats follow a same rhythmic wave pattern and rhythmic pattern varies in case of polymorphic ventricular tachycardia. People who previously had a heart attack or suffers from heart conditions such as myocardial infarction, structural heart disease, ischemic heart disease and are older in age are more likely at the risk of experiencing ventricular tachycardia. Some of the main symptoms for ventricular tachycardia includes fatigue, chest pain, fainting, shortened breath, dizziness, palpitations, cardiac arrests and seizures. It needs to be properly diagnosed in time by performing following diagnostic tests such as electrocardiogram; cardiac imaging which includes echo, MRI, CT scan, coronary angiogram and chest X-ray; stress test; electrophysiological test and other tests.

View Sample Report @ http://www.persistencemarketresearch.com/samples/17389

Depending upon the symptoms and severity of heart disorder, ventricular tachycardia treatment is broadly classified into two categories: emergency treatment for patients in distress and long-term treatment. Various anti-arrhythmic drugs such as Aminodarone, Lidocaine, Sotalol, Procainamide and Nifekalant are most commonly preferred to treat patients with ventricular tachycardia. These drugs treat unusual heart rhythms that originates due to error in electrical activity of heart.

Rising incidence of heart injuries such as myocardial infarctions and valvular heart disease is anticipated to be the primary factor fueling the ventricular tachycardia treatment market. Growing geriatric population with rising heart conditions such as heart attacks, changing lifestyle, rising inclination of patients for cardiomyopathy and heart surgery are some other factors which further drive the ventricular tachycardia treatment market. Moreover, advancing technology and enhanced treatment therapies is further anticipated to drive the market over forecast period. However, high costs associated with heart surgeries is restraining the current market growth.

Request to View Tables of Content @ http://www.persistencemarketresearch.com/toc/17389

On the basis of type of treatment, catheter ablation is most common treatment technique used to restore common rhythmic heartbeats. Also, owing to the promising success rates associated with catheter ablation treatment procedure, it is further anticipated to dominate over the forecast period.

Based on geography, global ventricular tachycardia treatment market is segmented into five key regions viz. North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America registered for the largest shares in global ventricular tachycardia treatment market followed by Europe and Asia-Pacific. North America region is anticipated to continue the same trend on the account of rise in number of deaths due to cardiac fatalities in U.S.

Some of the key players involved in global ventricular tachycardia treatment market are INOVYTEC MEDICAL SOLUTIONS Ltd., CU Medical Systems, Inc., Cardiac Science Co., Bexen Cardio, Advanced Instrumentations Inc., Baxter International Inc., Pfizer Inc., Heritage Pharmaceuticals Inc. and others.

To Buy Full Report for a Single User @ http://www.persistencemarketresearch.com/checkout/17389

About Us 
Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.

PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, PMR’s engagement models are highly flexible without compromising on its deep-seated research values.

Contact
Persistence Market Research Pvt. Ltd
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
media@persistencemarketresearch.com
Web:www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Ventricular Tachycardia Treatment Market Segmentation and Competitor Analysis Report 2017 – 2025 here

News-ID: 674528 • Views:

More Releases from Persistence Market Research

North America Wiring Devices Market Projected to Reach USD 26.46 Billion by 2031
North America Wiring Devices Market Projected to Reach USD 26.46 Billion by 2031
Overview of the North America Wiring Devices Market The North America wiring devices market is poised for steady growth over the forecast period, with its size estimated at US$ 18.96 billion in 2024, projected to reach US$ 26.46 billion by 2031, reflecting a CAGR of 4.9%. The market is witnessing substantial expansion due to increasing urbanization, a rising number of residential and commercial construction projects, and the adoption of energy-efficient and
Global Forged Automotive Components Market Poised for Steady Growth, Projected to Reach US$ 70.7 Billion by 2032
Global Forged Automotive Components Market Poised for Steady Growth, Projected t …
The global forged automotive components market is on a robust growth trajectory, currently valued at approximately US$ 50.3 billion in 2025 and forecasted to expand to US$ 70.7 billion by the end of 2032. This growth represents a compound annual growth rate (CAGR) of 5.0% over the coming decade, driven by increasing automotive production, technological advancements, and evolving consumer preferences toward durable, high-performance vehicle parts. Forged automotive components are critical to
Global Electric Cargo Bike Market Set to Accelerate at 11.9% CAGR, Reaching US$ 2.14 Billion by 2032, Reports Persistence Market Research
Global Electric Cargo Bike Market Set to Accelerate at 11.9% CAGR, Reaching US$ …
The global electric cargo bike market is set to experience substantial growth over the coming decade, with Persistence Market Research (PMR) forecasting a compound annual growth rate (CAGR) of 11.9% from 2023 through 2032. Valued at approximately US$ 800 million in 2021, the market is expected to surge to a projected valuation of US$ 2.14 billion by the end of 2032. Notably, electric cargo bikes accounted for 66.2% of the
Bicycle Bearings Market Set for Steady Growth with 6.5% CAGR Through 2032, Driven by Urbanization and Demographic Trends
Bicycle Bearings Market Set for Steady Growth with 6.5% CAGR Through 2032, Drive …
The global bicycle bearings market is poised for significant expansion over the forecast period of 2025 to 2032, according to the latest report released by Persistence Market Research. Valued at approximately US$ 5.99 billion in 2024, the market is projected to reach US$ 6.35 billion by 2025 and further escalate to nearly US$ 9.86 billion by 2032. This growth trajectory reflects a compound annual growth rate (CAGR) of 6.5%, underscoring

All 5 Releases


More Releases for Ventricular

Evolving Market Trends In The Left Ventricular Assist Devices Industry: Advancem …
The Left Ventricular Assist Devices Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Left Ventricular Assist Devices Market Size During the Forecast Period? In recent times, the market size for left ventricular assist devices has experienced considerable growth. The projections reveal an
Key Trends Shaping the Future Ventricular Fibrillation Market From 2025-2034: Te …
What Is the Estimated Market Size and Growth Rate for the Ventricular Fibrillation Market? In recent years, there has been a significant growth in the market size of ventricular fibrillation. The market, which is projected to expand from $6.13 billion in 2024 to $6.53 billion in 2025, is set to achieve a compound annual growth rate (CAGR) of 6.6%. Factors such as heightened awareness, a spike in heart-related conditions, advancements
Ventricular Assist Device Market - Supporting Hearts, Restoring Hope: Leading th …
Newark, New Castle, USA: The "Ventricular Assist Device Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Ventricular Assist Device Market: https://www.growthplusreports.com/report/ventricular-assist-device-market/7893 This latest report researches the industry structure,
Ventricular Assist Device Market - Embracing Life, Empowering Hearts: Redefining …
Newark, New Castle, USA - new report, titled Ventricular Assist Device Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Ventricular Assist Device market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Ventricular Assist Device market. The report offers an overview of
Ventricular Assist Device Market Forecast to 2032 - Covid-19 Impact and Global A …
Report Overview The global ventricular assist device market size was valued at USD 1.8 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 17.6% from 2023 to 2032. The increased prevalence of chronic conditions such diabetes, neurological disorders, cardiovascular diseases, hypertension, and stroke, as well as the expanding worldwide elderly population, are some of the key drivers that are projected to fuel demand for
05-08-2017 | Health & Medicine
SA-BRC
Ventricular Assist Devices (VAD) Market Assessment
Ventricular assist devices (VAD) are mechanical pumps used to support patients with a weakened heart or in case of heart failure to temporarily maintain heart function. The devices helps in re-establishing normal hemodynamics under conditions involving damaged ventricle. Increasing trend for sedentary lifestyle, rising obesity population globally, lifestyle changes and various other factors have resulted an increase in cardiovascular disorders. This rising prevalence across the globe has been a major